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Abstracts / International Journal of Surgery 23 (2015) S15eS134S16metabolic activity (p ¼ 0.002) and differentiation (p < 0.001) relative to
control glass substrates at day 7. Similar results were observed on gold, and
thiol surfaces were also found to initiate early neurodifferentiation in the
absence of trophic factors.
Conclusion: Organofunctionalisation potentially offers a simple and cost-
effective cross-platform technology through which the biocompatibility of
neurosurgical implants could be easily improved. Our results are highly
encouraging, yet it is now essential that work is repeated using a co-cul-
ture model to investigate the inﬂammatory component of device rejection.
0356: ORGAN DONATION REGISTRATION: EVIDENCE BASED
MARKETING?
R. Thomas 1,*, W. Scott 2, J. Forsythe 1, L. Marson 1. 1University of Edinburgh,
UK; 2 Scottish Government, UK
Aim: 778 Scots are waiting for a transplant and last year 43 died whilst
waiting. Only 42% of eligible Scots are on the organ donor register (ODR).
Apathy is a barrier: 32% of those unregistered said they would join,
demonstrating a potential focus for a targeted marketing campaign.
Methods: In 2005, the Scottish “Kill Jill” campaign focused on the
contemporary trend of voting for outcome (cost: £325,000). In 2008,
the “Connected”marketing had amore personal approach (cost: £615,000).
Results: “Kill Jill” increased new Scottish registrations by 33%, compared to
the 6.5% English increase over the same period. The 108,423 new regis-
trations should mean six additional renal transplants over a decade. The
subsequent “Connected” campaign generated 34,729 more registrations, a
1.8% growth in ODR. It was predicted that this would result in 2.6 extra
transplants.
Conclusion: Marketing is expensive and results are difﬁcult to quantify.
One renal transplant saves £214 000 per person compared to dialysis. If
only one of 108,423 donates both kidneys after death, the “Kill Jill”
campaign has paid for itself. The “Connected” campaign predicted that
each £1 spent, saves the NHS £5.28. ODR campaigns deliver a healthy re-
turn-of-interest and the initial considerable outlay should result in many
lives transformed and saved.0685: EXPLORING THE TUMOUR STROMA MACROPHAGES TO IDENTIFY
RESPONDERS TO RADIOTHERAPY IN LOCALLY ADVANCED RECTAL
CANCER
S. Shaikh*, A. Noshirwani, N. West, S. Perry, T. Maisey, D. Jayne. University
of Leeds, UK
Aim: Only half the patients with locally-invasive-rectal-carcinoma (LIRC)
respond to short-course-preoperative-neoadjuvant radiotherapy(SCPRT).
A predictive test enabling better patient selection could avoid undue ra-
diation exposure to poor-responders. Macrophages within the tumour
immune microenvironment with tumouricidal M1 and tumour-protective
M2 phenotypes could be modulating this response. This study investigates
the possible predictive value of M1 and M2 in identifying patients’ likely
response to SCPRT.
Methods: Dual-staining immunohistochemistry was performed on 29
biopsy and post-SCPRT resection LIRC specimens with CD68 as macro-
phagemarker, Human-Leukocyte-Antigen-DR(HLA-DR) as M1-marker and
Cluster-of-Differentiation-163(CD163) as M2-marker. Specimens were
scored for hot-and-random spots by Nuance-3.0.2 and compared with
patients’ outcome data.
Results: A signiﬁcant difference was found for high and low M1 percent-
ages with a tumour response of 20% and 80%, respectively (p ¼ 0.017). No
such difference was found for M2. The ratio of M1/M2 in biopsy vs.
resection samples was found to be signiﬁcantly different (p < 0.05), and
change in ratio producing a signiﬁcant mean (p ¼ 0.024).
Conclusion: Patients with a variable macrophage phenotype composi-
tion within LIRC biopsies respond differently to SCPRT. Further inves-
tigation involving a panel of macrophage/other immune-cell
markers could verify and validate these ﬁndings and develop them as
predictive tests identifying good-responders to radiotherapy in patients
with LIRC.0739: HEAD AND NECK CANCER DETECTION: THE EFFICACY OF THE 2-
WEEK-WAIT REFERRAL PATHWAY
T. Tikka 1,*, P. Pracy 1, V. Paleri 2. 1Queen Elizabeth Hospital, UK; 2 Freeman
Hospital, UK
Aim: Identify signiﬁcant factors in correct cancer diagnosis through the
ENT 2-week-wait referral pathway.
Methods: Retrospective review of 5083 patients' notes with possible head
and neck caner who were referred through the 2-week-referral pathway
from 2007 to 2010 in 2 tertiary UK Hospitals. Multivariate binary logistic
regression analysis was performed to identify signiﬁcant factors in cancer
diagnosis. The ﬁnal model was compared to amodel created by the current
NICE guidance.
Results: Low sensitivity and high speciﬁcity was found for all presenting
symptoms. Presence of hoarseness for more than 6 weeks; dysphagia for
more than 3 weeks; presence of blood in mouth with concurrent sensation
of lump in throat; the sensation of lump in neck ; sore throat; otalgia;
odynophagia; presence of otalgia with concurrent lump in throat sensa-
tion are highly statistically signiﬁcant symptoms for correct diagnosis of an
ENT cancer. Our ﬁnal suggested model has higher predictive value in
correct cancer diagnosis comparing to the NICE guidance model.
Conclusion: The current NICE referral guidance failed to increase detec-
tion rates of ENT cancers. We are recommending a new national referral
checklist, based on our logistic regression analysis, to be used by General
Practitioners when assessing patients with probable ENT cancer.
0777: A PROSPECTIVE STUDY OF CART, CHROMOGRANIN A,
CHROMOGRANIN B AND PANCREATIC POLYPEPTIDE IN THE
DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMOURS
S. Singagireson*, N. Martin, K. Murphy. Imperial College London, UK
Aim: Biochemical markers are an integral part of pancreatic neuroendo-
crine tumour (pNET) diagnosis, however, the current gold standard of
biomarkers, chromogranin-A (CgA) has signiﬁcant limitations. Recent
research has suggested other circulating markers including cocaine-and-
amphetamine-regulated-transcript (CART), chromogranin-B(CgB) and
pancreatic polypeptide(PP) may have utility as pNET diagnostic markers.
To investigate the sensitivities and speciﬁcities of measuring circulating
CART, CgA, CgB and PP for pNET diagnosis.
Methods: Plasma samples were obtained from patients with pNETs, non-
neuroendocrinepancreaticdisease (NNPD)andnon-pancreaticdisease (NPD)
and circulating concentrations of CART, CgA, CgB and PP were measured.
Results: Circulating CART was the only marker signiﬁcantly elevated by
pNETs compared to NPD (48.00 (35.75e67.00 pmol/L) [NPD] vs. 89.00
(66.00e147.0 pmol/L) [pNET], p < 0.01, n ¼ 7e42). CART was the most
sensitive marker for pNETs, with a sensitivity of 71%, compared to 29%,
25%, and 0% for CgA, CgB and PP respectively. It also had a speciﬁcity of 88%,
which was lower than the speciﬁcities of CgA, CgB and PP with 100%, 98%,
94% respectively.
Conclusion: These data suggest that circulating CART may be a more
sensitive and reliable marker than CgA, CgB or PP in pNET diagnosis which
may result in earlier diagnosis and so a greater proportion of resectable
tumours at presentation.
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0065: COGNITIVE TASK ANALYSIS PERFORMANCE OF SURGICAL
TRAINEES USING AN OPEN HERNIA REPAIR SIMULATOR
A.O. Rae*, M. Khatib, S. Sarker, F. Bello. Imperial College London, UK
Aim: To evaluate the use of an interactive open hernia simulator on the
cognitive task analysis performance of trainees compared to other
methods of acquiring the knowledge for the operation.
Methods: 32 foundation and core surgical trainees were randomised to
receive 1 of 4 interventions (interactive open hernia repair simulator) G1,
non-interactive open hernia repair simulator G2, a video tutorial of the
